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Abstract
Background: Although sarcoidosis and celiac disease are both chronic immunologic disorders involving multiple
organ systems, reports about association of diseases in individual patients are sparse. While sarcoidosis is a chronic
granulomatous disease presumably reflecting an exaggerated response to an unknown antigen, celiac disease is a T
cell-driven disease triggered by ingestion of gluten, a protein composite found in wheat and related grains.
Case presentation: We present three cases with a longstanding history of sarcoidosis that have been additionally
diagnosed with celiac-like enteropathy. In two cases, celiac disease was established applying celiac-specific serology
and duodenal histology, while one case was revealed as an AIE-75-positive autoimmune enteropathy.
The HLA-DR3/DQ2 haplotype was confirmed in both celiac patients, hence confirming previous data of linkage
disequilibrium as a cause for disease association. Remarkably, one celiac patient presented with granulomatous
nodulae in the ileum, thus reflecting an intestinal sarcoid manifestation. In contrast the patient with an autoimmune
enteropathy, was HLA-DQ9/DQ6-positive, also arguing against CD.
Conclusions: Associations of sarcoidosis and celiac disease are rare but do occur. Determining the HLA status in
patients with complex autoimmune associations might help classifying involved disease entities.
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Background
In 1984, Douglas et al. reported on five patients with the
combined diagnoses of celiac disease (CD) and sarcoid-
osis [1]. Since then, other authors provided evidence for
an association of these disorders. However, evidence
remains limited to a small number of case reports [2, 3]
and studies [4–6].
CD is a chronic inflammatory small intestinal disease
with a prevalence of 1 % induced by gluten and related
storage proteins of wheat, barley, and rye. Its pathogenic
keystone is the presentation of processed gliadin peptides
by human leukocyte antigen (HLA)-DQ2 and -DQ8 mole-
cules hence triggering an adaptive immune response
against various structures of the duodenal mucosa [7]. At
the peak of inflammation, the architecture of the small in-
testinal mucosa is severely altered (i.e. villous atrophy,
crypt hyperplasia and increased numbers of intraepithelial
T cells) resulting in malabsorption. Most CD patients, who
succeed to eliminate gluten from their diet, will achieve
regeneration of their duodenal mucosa with subsequent
clinical normalization. Population-based twin studies re-
vealed a strong genetic component of CD [8]. These
studies were followed by genome-wide association studies
elucidating the genetic complexity of CD with HLA class II
alleles as major contributing factors [9].
A small percentage of patients with CD will not re-
spond to a gluten-free diet (GFD). In these cases, refrac-
tory celiac disease (RCD) should be considered after
reviewing stringency of GFD and exclusion of other dif-
ferential diagnoses. In RCD type I, intraepithelial lym-
phocytes (IEL) are characterized by normal expression
of T-cell antigens as well as polyclonal T-cell receptor
gene rearrangement. RCD type I is responsive to im-
munosuppressive treatment. In contrast, monoclonality
of IEL accompanied by loss of T-cell antigens defines
RCD type II that is nowadays regarded as an early stage
of an enteropathy-associated T cell lymphoma [10].
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Sarcoidosis is a multiorgan disease predominantly af-
fecting lung, skin, and eyes with the pathologic hallmark
of granuloma formation. Its aetiology is still enigmatic.
The current literature suggests an exaggerated immune
response to non-degradable pathogen-associated mo-
lecular patterns of mycobacteria and propionibacteria
but also other organic and inorganic particles. The
prevalence of sarcoidosis ranges from 4.7-64:100000 in-
dividuals with highest rates in northern Europeans and
African-Americans [11].
Common presenting symptoms of sarcoidosis include
fatigue, persistent cough, skin lesions, erythema nodosum,
and incidental pathologic findings on chest radiograph.
Diagnosis should be based on three criteria: (i) compatible
clinical presentation, (ii) evidence of non-caseating
epithelioid-cell granulomas, and (iii) exclusion of alterna-
tive granulomatous disorders [12]. Evidence from genetic
association studies suggest that sarcoidosis is a heteroge-
neous disease with distinct subgroups as particular HLA
class II alleles influence the course of disease. While HLA-
DR3 predisposes to an acute self-limiting course as seen in
Löfgren’s syndrome, HLA-DR14 and -DR15 are associated
with chronic disease. Interestingly, it was shown for sar-
coidosis that HLA-DR3 is in strong linkage disequilibrium
with HLA-DQ2 leading to an equally strong association of
the latter to a favourable course [13].
Both CD and sarcoidosis are complex diseases and the
establishment of a definite diagnosis can be difficult in
individual cases. Here we report on three patients with
longstanding courses of autoimmune disease reflected by
a malabsorptive syndrome with duodenal villous atrophy
and a sarcoid-like granulomatosis. The differential diagno-
sis in particular with regard to refractory CD will be dis-
cussed based on a thorough clinical work-up, including
genetic and immunological testing, that aimed to shed
light on the pathophysiology of the disease association.
Consent
Written informed consent was obtained from the pa-
tients for publication of the case reports and any accom-
panying images. A copy of the written consent is
available for review by the Editor of this journal.
Case presentations
For clinical characteristics refer to Table 1.
Patient A
A 54-year-old Caucasian woman presented with a clin-
ical symptomatology suggestive for autoimmunity at the
age of 32, when she presented with Sicca syndrome and
arthralgias. A positive Schirmer’s test, a lip biopsy reveal-
ing B and T cell infiltrates, and positive autoantibodies
Table 1 Patient characteristics
Patient A B C
Major complaints Sicca syndrome, arthralgias,
chronic diarrhoea, weight loss
Dyspnoea on exertion, chronic
diarrhoea, weight loss, gait
abnormalities
Chronic diarrhoea since childhood,
weight loss, arthralgias
Malabsorptive syndrome
Age at dx 33 years 34 years 35 years





Serology Tg-IgA positive Tg-IgA repeatedly negative,
AIE-75 antibodies elevated
Gliadin-IgA/IgG elevated
Response to GFD Temporary improvement of
symptoms, normalization of
histologic and serologic findings




histologic and serologic findings
Currently on GFD Yes No Yes
Granulomatous disease
Age at dx 36 years 22 years 35 years
















dx, diagnosis; Tg, transglutaminse; AIE-75, autoimmune enteropathy related antigen, 75 kDa; CIDP, chronic inflammatory demyelinating polyneuropathy
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including SS-A(Ro) and SS-B(La) supported the diagnosis
of Sjögren’s syndrome.
One year later, CD was suspected since the patient
was suffering from chronic diarrhoea and weight loss,
but unfortunately no further diagnostic measures were
taken. At the age of 41 duodenal biopsies revealed total
villous atrophy (Marsh IIIc) and GFD was introduced,
which initially resulted in a significant improvement of
symptoms. However, during the following 17 years she
complained about remitting episodes of diarrhoea. Duo-
denal biopsies repeatedly confirmed villous atrophy,
hence leading to the suspicion of RCD and the referral
to our centre. Thus, at 50 years of age, the patient
presented to our clinic. At this time transglutaminase
(Tg)-IgA antibodies were positive, duodenal mucosa
showed intraepithelial lymphocytosis without crypt
hyperplasia or villous atrophy (Marsh I). After optimiz-
ing GFD, symptoms ameliorated and Tg-IgA turned
negative, altogether suggesting incomplete GFD as the
underlying cause for villous atrophy. When the patient
presented again with diarrhoea at the age of 53 the duo-
denal mucosa appeared normal (Marsh 0) and Tg-IgA
were negative. Duodenal IEL revealed a normal pheno-
type and an oligoclonal pattern. Colonic biopsies dis-
played a thickened collagen band compatible with the
diagnosis of collagenous colitis.
Sarcoidosis was diagnosed at the age of 36 when a
chest radiograph incidentally revealed intrathoracic
lymph node enlargement. Consecutive bronchial biopsies
revealed an atrophic mucosa containing epithelioid-cell
granulomas without central necrosis as they are typically
found in sarcoidosis. Staining for acid-fast bacilli was
negative. The CD4/CD8 ratio of bronchial lymphocytes
was 0.8 and the patient received a course of prednisol-
one (initially 40 mg qd that were tapered over a 6 months
time period). 18 years later she presented with fatigue
and an elevated erythrocyte sedimentation rate (1st hour:
78 mm). A CT-scan of the chest revealed bi-pulmonic
interlobular septal thickening and ground-glass opacities.
Bronchial mucosa appeared inflamed. Again, no evidence
of mycobacterial infection was present as interferon-γ re-
lease assay, staining for acid-fast bacilli, and mycobacterial
cultures from broncho-alveolar lavage all turned out to be
negative. Serum soluble interleukin-2 receptor (sIL-2r) was
elevated, hypercalcaemia was not present. At the same
time extractable nuclear antigen antibodies, SS-A(Ro),
SS-B(La), and gamma globulins were increased. HLA-
typing revealed the DR3/DQ2 alleles (Table 2).
Patient B
The 59-year-old Caucasian male presented first at the
age of 22 with dyspnoea on exertion and radiographic
signs of pulmonary disease. Bronchial biopsies indicated
epithelioid-cell granulomas and sarcoidosis was diagnosed.
During the following decades his disease progressed to
stage IV pulmonary sarcoidosis with bi-pulmonic fibrosis
and bi-hilar lymphadenopathy accompanied by diffuse ab-
dominal lymphadenopathy. Pulmonary mycobacteriosis
was excluded repeatedly by negative staining for acid-fast
bacilli, negative polymerase chain reaction forM. tuberculosis
DNA, and negative mycobacterial cultures of broncho-
alveolar lavage material. Furthermore, no evidence was
found for fungal infection or presence of anorganic parti-
cles as an underlying cause of pulmonic granuloma
formation. Lymph node extirpations from the groin and the
hepatoduodenal ligament revealed epithelioid-cell granu-
lomas. Serum levels of sIL-2r, calcium, 1,25-dihydroxy-vitamin
D, and angiotensin converting enzyme were repeatedly
elevated. However, a rheumatologic workup including
anti-neutrophil cytoplasmic antibodies turned out nega-
tive. He therefore received several courses of steroid
treatments.
CD was diagnosed at the age of 34 as the patient suf-
fered from chronic diarrhoea and weight loss. The pa-
tient recalled later that at this stage the diagnosis was
based solely on the finding of duodenal atrophy but not
on serology. For the following 23 years the patient
followed a strict GFD, however with relapsing episodes
of diarrhoea and weight loss. Repeatedly, duodenal biop-
sies proved total villous atrophy with crypt hyperplasia
and intraepithelial lymphocytosis. At these follow-up
visits to our clinic, CD-associated antibodies (Tg-IgA/
IgG, endomysium-antibodies, gliadin-IgA/IgG) were an-
alyzed but turned out to be negative. In addition, antigen
expression and T-cell receptor gene rearrangement ana-
lyses of IEL did not indicate monoclonality.
Secondary to a diagnosis of warm antibody hemolytic
anaemia at the age of 47, treatment with steroids was
initiated again with maximum doses of up to 150 mg
prednisolone qd, which was extended to cyclophospha-
mide, mycophenolate, and finally splenectomy as well as
rituximab. Interestingly, immunosuppressive treatment
was paralleled by amelioration of diarrhoea and duo-
denal mucosal findings. When the patient presented
again with diarrhoea at the age of 52, autoimmune en-
teropathy (AIE) related antigen-75 antibodies were ana-
lyzed and found to be significantly elevated. Based on
Table 2 HLA status
Patient A B C
HLA class I A1/A68 n.d. n.d. except for negativity of B27
B7/B8
C2/C7
HLA class II DR3/DR15 DR9/DR15 DR3/DR16
DQ2 DQ6/DQ9 DQ2/DQ5
n.d., not done
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these findings, AIE was diagnosed and treatment with
azathioprine initiated. At 53 years of age the patient
developed acute autoimmune hepatitis that required
escalation of immunosuppressive treatment. Later on,
GFD was discontinued without worsening of abdominal
symptoms. Six months after the re-introduction of glu-
ten, Tg-IgA remained negative and duodenal mucosa
was normal except for a moderate lymphocytosis. Corre-
sponding to the previous findings, HLA-typing revealed
that he neither carried the DQ2- or DQ8-haplotype, but
the DQ6/DQ9 and DR9/DR15 alleles (Table 2). Taking
all criteria together, the patient never had CD.
Beginning at the age of 47, patient B suffered from a
complex neurological disorder. He presented with gait
abnormalities that corresponded to a slowly progressive
spastic paraparesis, obstipation and overflow incontin-
ence. Extensive diagnostics included normal MRI scans
of the cranium and spine. Transcranial motor cortex
stimulation showed signs of first motor neuron degene-
ration explaining the spastic paraparesis. Lumbar punc-
tures revealed moderate lymphomonocytic pleocytosis
(cell counts ranging from 9-13/μl) and mild disturbances
of the blood–brain barrier, but a lack of intrathecal
immunoglobulin synthesis. Sensorimotor polyneuro-
pathy was diagnosed by electroneurography (ENG) with
slightly reduced nerve conduction velocities and in-
creased F wave latencies. A biopsy of the sural nerve
showed demyelination. With multiple previous auto-
immune disorders in mind two diagnoses were made:
(i) a presumably immune-mediated myelopathy being
responsible for most of his focal neurological symptoms
including spastic paraparesis and (ii) chronic inflamma-
tory demyelinating polyneuropathy (CIDP), explaining
demyelination, ENG, and liquor results. Lacking an ad-
equate treatment for myelopathy, treatment focussed on
CIDP. Thus, he received intravenous immunoglobulins
(IvIg). Symptoms did not improve with therapy. How-
ever, IvIg application was continued to avoid deterior-
ation of CIDP.
Patient C
Since childhood the 47-year-old Caucasian male was suf-
fering from chronic abdominal discomfort, bloating,
diarrhoea, and weight loss. At the age of 35 CD was
suspected for the first time when duodenal biopsies
revealed total villous atrophy and crypt hyperplasia.
Gliadin-antibodies were highly positive. CD was also di-
agnosed in two of his brothers and in his niece. At the
same time a CT-scan of the abdomen revealed iliac,
paraaortic, and mesenteric lymphadenopathy as well as
splenomegaly. Lymph node analysis showed epithelioid-
cell granulomas without any histopathological evi-
dence for mycobacteriosis. The patient started a GFD
that led to partial improvement of his symptoms and
normalization of duodenal mucosa as well as Tg-, gliadin-,
and endomysium-antibodies. However, episodes of abdom-
inal discomfort and diarrhoea remitted. Neither duodenal
histology nor flow cytometric analysis of IEL indicated an
abnormal IEL phenotype. Repeated colonoscopies per-
formed between the ages of 41 to 46 years revealed a fol-
licular hyperplasia of the terminal ileum without any
evidence for mucosal ulcerations as typically found in
Crohn’s disease (Fig. 1). Histology of one biopsy from
the terminal ileum uncovered epithelioid-cell granulomas.
A thorough work-up for an underlying infectious disease
was inconclusive, except for positive antibodies against
Yersinia spp. HLA-typing revealed the carriage of DR3/
DQ2 (Table 2).
From the age of 44 onwards, the patient suffered from
painful erythema nodosum of both legs accompanied by
arthralgias of multiple joints. He also complained about
severe fatigue and persistent cough. Chest radiograph,
bodyplethysmography, and bronchoscopy were without
pathological findings. In particular, bronchoscopy did
neither reveal any evidence for granuloma of any type
nor for M. tuberculosis by microscopy, polymerase chain
reaction and mycobacterial culture. A rheumatologic
work-up including Rheumatoid factor, anti-nuclear anti-
bodies, anti-neutrophil cytoplasmic antibodies, testing
on HLA-B27 and MRI of lumbar spine and sacroiliac
joints was not conclusive. Functional testing of immune
cells did not support chronic granulomatous disease.
In summary, case C includes the diagnoses CD and a
granulomatous disease, partially resembling Löfgren’s
syndrome, the latter being not only supported by the
record of granulomata found in an enlarged lymph node
but also by carriage of HLA-DR3.
Conclusions
Although the first description of patients with combined
diagnoses of CD and sarcoidosis dates back to 1984 [1],
clinical evidence of disease association has remained
sparse ever since. In a first systematic investigation on
intestinal immune reactivity in sarcoidosis increased
gliadin-antibodies were present in 41 % of sarcoidosis
patients compared to 5 % in controls whereas no differ-
ences were observed in antibody levels against casein,
β-lactoglobulin, and ovalbumin. Independent of gliadin-
antibodies, IEL counts were significantly raised in sar-
coidosis patients [14]. Elevated gliadin-antibody levels in
sarcoidosis patients were found in another study, but no
alterations in IEL counts or villous atrophy were ob-
served [4]. Retrospectively, one might critically assume
that gliadin serology can be false-positive at high rates in
patients in whom other autoimmune disorders are already
known [15].
However, a case–control study investigating the preva-
lence of CD amongst patients with sarcoidosis reported
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a trend to a higher prevalence (4 % in sarcoidosis pa-
tients when compared to 1 % in controls). Interestingly,
80 % of sarcoidosis patients being additionally diagnosed
with CD were HLA-DR3/DQ2 carriers, suggesting a
genetic link between both diseases [5].
Inversely, a case control study investigating 335 CD
patients identified five cases of sarcoidosis compared to
none in the control group [16]. Most recently, a data-
based review of 866 biopsy proven cases of CD revealed
10 cases of sarcoidosis, hence being 33-fold higher than
the expected number in a matching Caucasian American
population [6].
In Caucasians, CD and sarcoidosis are often linked to
a highly conserved haplotype, called the 8.1 ancestral
haplotype. Amongst HLA-DR3/DQ2, it further contains
the HLA-A1, −B8, C4A null, and tumor necrosis factor
(TNF)-α-308 alleles. It has been associated with numer-
ous autoimmune disorders (including Sjögren’s syn-
drome, dermatitis herpetiformis, IgA-deficiency or
insulin-dependent diabetes mellitus) possibly due to an in-
creased transcription of TNF-α and reduced complement-
mediated antigenic clearance [17]. To our knowledge no
overlap in non-HLA risk genes has been described be-
tween CD and sarcoidosis.
With these reports in mind, we searched for patients
with the combined diagnoses of CD and sarcoidosis at
our institution and subsequently identified three patients
with malabsorptive syndromes secondary to duodenal
villous atrophy and a granulomatous disease.
Based on the positive serology, duodenal histology and
the normalization of symptoms after introduction of
GFD, the diagnosis of CD could be established in pa-
tients A and C. Interestingly, both share the HLA-DR3/
DQ2 haplotype. Moreover, in patient A, collagenous
colitis and Sjögren’s syndrome, diseases likely to be asso-
ciated with CD, were established [18]. In patient C, the
finding of epithelioid-cell granulomas initially raised the
suspicion of Crohn’s disease. However, this could not be
confirmed, as no other findings supported this diagnosis.
In conjunction to lymph node granulomas, frequent ery-
thema nodosum and the genotype, the ileal epithelioid-
cell granulomas were interpreted as an intestinal mani-
festation of sarcoidosis.
Patient B adhered to GFD for 23 years due to the pu-
tative diagnosis of CD – however, without convincing
relief of malabsorption-associated symptoms. Since
celiac-specific serology was negative, GFD did not im-
prove symptoms, HLA-DQ2 and -DQ8 analysis were
negative and anti-enterocyte AIE-75 antibodies were
found to be positive, AIE was diagnosed and GFD was
discontinued. AIE is a rare disease that mainly occurs in
children and young adults, but may also affect elderly
patients. Proposed diagnostic criteria from the so far lar-
gest case series include adult-onset protracted diarrhoea
A 
B 
Fig. 1 Ileal findings of patient C. a) Ileocolonoscopic follicular
hyperplasia. b) Hematoxylin and eosin staining of ileal biopsies
showing multinucleated macrophages (asterisks) and an epithelioid-cell
granuloma (black arrow)
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not responsive to any dietary exclusion and associated
with intestinal villous atrophy, circulating gut autoanti-
bodies (e.g. against enterocytes or goblet cells), and/or
predisposition to autoimmunity. About 60 % of the adult
cases presented with abdominal lymphadenopathy on
CT, a finding also observed in patient B. AIE tends to be
unremitting without aggressive immunosuppression but
complete or partial remission can be achieved in about
60-80 % of patients [19]. Normalisation of the duodenal
mucosa despite discontinuation of GFD as observed in
this patient might be due to the immunosuppression he
received for his other autoimmune diseases.
Patients A and B displayed findings in line with the
diagnosis of sarcoidosis including clinical symptoms,
radiologic evidence of pulmonary disease, and epithelioid-
cell granulomas. However, two findings of patient A argue
against sarcoidosis. First, the comorbid diagnosis of
Sjögren’s syndrome. Estimations of lung involvement in
Sjögren’s syndrome vary widely from 7-75 % with nonspe-
cific interstitial pneumonitis being the most common form
of interstitial disease manifestation. Although recent evi-
dence suggests the coexistence of sarcoidosis and Sjögren’s
syndrome in the same individual and even argues for a
true association [20], the American-European study group
on classification criteria for Sjögren’s syndrome stated in
2002 both diseases would exclude each other [21]. Second,
patient A’s bronchial CD4/CD8 ratio was <3.5, a finding
with a negative predictive value of 85 % for the diagnosis
of sarcoidosis [12]. In this case, the interdisciplinary in-
flammation team at our centre continued to work with a
diagnosis of sarcoidosis since it best explained the granu-
lomatous disease.
Besides CD, patient C suffered from a chronic granu-
lomatous disease including abdominal lymphadenopathy
with proven epithelioid-cell granulomas and severe
erythema nodosum. His symptoms included fatigue, ar-
thralgias, and persistent cough. Pulmonary findings were
normal. Repeated examinations did not reveal further
evidence for Crohn’s disease, a particular rheumatologic
or infectious disease. Sarcoidosis is a diagnosis of exclu-
sion. However, without hilar lymphadenopathy the diag-
nosis should be made cautiously. In the so far largest
case control series of sarcoidosis, 8 % of patients had
a normal chest radiograph and 2 % had only extra-
thoracic disease [22]. Technically, the clinical presen-
tation together with epithelioid-cell granulomas and
the lack of clear evidence supporting alternative diag-
noses fulfil the diagnostic criteria of extra-thoracic
sarcoidosis.
Patients B represents to our knowledge the first case
reported so far with the combined diagnoses of AIE and
sarcoidosis. It also illustrates that HLA typing might
serve to exclude CD. The case further exemplifies how
difficult it might be to define exact diagnoses in patients
with complex autoimmune diseases, a fact that may bias
association studies.
A large body of evidence links distinct HLA variants
to either sarcoidosis or CD. In the latter, the HLA-DQ
locus appears to have the biggest impact on disease de-
velopment with the majority of patients carrying a vari-
ant of HLA-DQ2 (DQA1*05/DQB1*02) and only 5 %
carrying HLA-DQ8 [23]. On the other hand, the HLA-
DR3, −DR11, −DR12, −DR14, and -DR15 alleles are
established risk factors for sarcoidosis with the HLA-
DR3 haplotype being typically associated with Löfgren’s
syndrome [24]. Evidence from clinical and genetic
studies support an association of CD and sarcoidosis
most likely due to linkage disequilibrium of HLA-DQ2
and -DR3. Patients A and C may exemplify this. A simi-
lar mechanism appears to underlie the association of CD
with other autoimmune diseases that are linked to the
common ancestral haplotype 8.1.
In summary, this case series exemplifies rare coinci-
dences of granulomatous inflammations/sarcoidosis and
CD/autoimmune enteropathy. These cases as well as
others described in the literature underline the relevance
of a distinct genetic HLA configuration for the develop-
ment of these diseases. Besides, the case of patient B
suggests that the diagnosis of CD should be reconsid-
ered in patients without persuading improvement to
GFD. In such peculiar cases different diagnostic methods
may be required to rule out RCD including HLA-typing
as well as antigen expression and T-cell receptor gene
rearrangement analyses of IEL. In cases with retrospect-
ively low probability for CD, GFD should be discontinued
in favour of quality of life. However, consecutive control
examinations should exclude deterioration thereafter.
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